---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024915"
form_type: "8-K"
ticker: null
cik: "0001415684"
company_name: "MusclePharm Corp"
filed_at: "2023-07-19T23:59:59+00:00"
generated_at: "2026-06-13T06:19:57.991580+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MusclePharm terminates CFO Gary Shirshac; names Anthony Todaro interim CFO

## Summary
- Gary Shirshac terminated as CFO effective July 10, 2023.
- Anthony Todaro appointed as interim CFO as of same date.
- Company remains in Chapter 11 bankruptcy (filed Dec. 15, 2022, case 22-14422).
- Monthly operating reports from the bankruptcy case attached as exhibits.

## SEC filing metadata
- accession: 0001493152-23-024915
- form_type: 8-K
- cik: 0001415684
- company_name: MusclePharm Corp
- filed_at: 2023-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1415684/000149315223024915/0001493152-23-024915-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1415684/000149315223024915/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024915
- JSON: https://secwatch.observer/filing/0001493152-23-024915.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024915.txt

## Key facts
- Executive change
  Gary Shirshac was terminated as Chief Financial Officer at MusclePharm Corp.
  - Action: terminated
  - Role: Chief Financial Officer
  source text: Effective as of July 10, 2023, MusclePharm Corporation (the “Company”) terminated Chief Financial Officer, Gary Shirshac.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1415684/000149315223024915/0001493152-23-024915-index.htm
- Executive change
  Anthony Todaro was appointed as interim Chief Financial Officer at MusclePharm Corp.
  - Action: appointed
  - Role: interim Chief Financial Officer
  source text: As of this filing, Anthony Todaro has been named as the Company’s interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1415684/000149315223024915/0001493152-23-024915-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.